Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Inhibrx Biosciences (INBX) Interest Coverage Ratio: 2023-2025

Historic Interest Coverage Ratio for Inhibrx Biosciences (INBX) over the last 2 years, with Sep 2025 value amounting to -10.63.

  • Inhibrx Biosciences' Interest Coverage Ratio was N/A to -10.63 in Q3 2025 from the same period last year, while for Sep 2025 it was -10.72, marking a year-over-year change of. This contributed to the annual value of -24.57 for FY2024, which is 256.83% down from last year.
  • As of Q3 2025, Inhibrx Biosciences' Interest Coverage Ratio stood at -10.63, which was down 21.90% from -8.72 recorded in Q2 2025.
  • Inhibrx Biosciences' Interest Coverage Ratio's 5-year high stood at -5.62 during Q3 2023, with a 5-year trough of -30.01 in Q2 2024.
  • Over the past 3 years, Inhibrx Biosciences' median Interest Coverage Ratio value was -9.85 (recorded in 2024), while the average stood at -12.07.
  • Per our database at Business Quant, Inhibrx Biosciences' Interest Coverage Ratio plummeted by 418.64% in 2024 and then soared by 70.95% in 2025.
  • Inhibrx Biosciences' Interest Coverage Ratio (Quarterly) stood at -10.74 in 2023, then tumbled by 418.64% to -30.01 in 2024, then surged by 70.95% to -10.63 in 2025.
  • Its Interest Coverage Ratio stands at -10.63 for Q3 2025, versus -8.72 for Q2 2025 and -15.95 for Q1 2025.